作者
P-J Touboul, MG Hennerici, S Meairs, H Adams, P Amarenco, N Bornstein, L Csiba, M Desvarieux, S Ebrahim, M Fatar, R Hernandez Hernandez, M Jaff, S Kownator, P Prati, T Rundek, M Sitzer, U Schminke, J-C Tardif, A Taylor, E Vicaut, KS Woo, F Zannad, M Zureik
发表日期
2007/1/1
期刊
Cerebrovascular diseases
卷号
23
期号
1
页码范围
75-80
出版商
S. Karger AG
简介
Intima-media thickness (IMT) is increasingly used as a surrogate end point of vascular outcomes in clinical trials aimed at determining the success of interventions that lower risk factors for atherosclerosis and associated diseases (stroke, myocardial infarction and peripheral artery diseases). The necessity to promote further criteria to distinguish early atherosclerotic plaque formation from thickening of IMT and to standardize IMT measurements is expressed through this updated consensus. Plaque is defined as a focal structure that encroaches into the arterial lumen of at least 0.5 mm or 50% of the surrounding IMT value or demonstrates a thickness> 1.5 mm as measured from the media-adventitia interface to the intima-lumen interface. Standard use of IMT measurements is based on physics, technical and disease-related principles as well as agreements on how to perform, interpret and document study results …
引用总数
学术搜索中的文章
PJ Touboul, MG Hennerici, S Meairs, H Adams… - Cerebrovascular diseases, 2007